|
|
by Németh, Bertalan, Csanádi, Marcell, Inotai, András, Ameyaw, David
Published 2022
“... on financing high-priced medicines. The market access strategies for innovative medicines in LICs usually...”Published 2022
World Health Organization
|
|
by Lemmens, Trudo, Ghimire, Kanksha Mahadevia, Perehudoff, Katrina, Persaud, Navindra
Published 2022
“...High prices can significantly restrict access to medicines and may have an impact on health equity...”Published 2022
World Health Organization
|
|
by Kroezen, Marieke, Buchan, James, Dussault, Gilles, Glinos, Irene A.
Published 2016
“... makes it more likely that patients will receive high-quality specialized care in their own country.2...”Published 2016
European Observatory on Health Systems and Policies
|
|
by Kroezen, Marieke, Buchan, James, Dussault, Gilles, Glinos, Irene A.
Published 2016
“... makes it more likely that patients will receive high-quality specialized care in their own country.2...”Published 2016
European Observatory on Health Systems and Policies
|
|
by Vogler, Sabine, Paris, Valérie, Panteli, Dimitra
Published 2018
“...1. Policy-makers and purchasers increasingly face very high price tags for new medicines, and some...”Published 2018
World Health Organization, Regional Office for Europe
|
|
by Vogler, Sabine, Paris, Valérie, Panteli, Dimitra
Published 2018
“...1. Policy-makers and purchasers increasingly face very high price tags for new medicines, and some...”Published 2018
World Health Organization, Regional Office for Europe
|
|
by Hanney, Stephen, Kanya, Lucy, Pokhrel, Subhash, Jones, Teresa
Published 2020
“...High-quality research is important for improving population health and well-being and for achieving...”Published 2020
WHO Regional Office for Europe
|
|
by Hanney, Stephen, Kanya, Lucy, Pokhrel, Subhash, Jones, Teresa
Published 2020
“...High-quality research is important for improving population health and well-being and for achieving...”Published 2020
WHO Regional Office for Europe
|
|
by Moon, Suerie, Vieira, Marcela, Alonso Ruiz, Adrián, Navarro, Danielle
Published 2022
“...Public concern has been increasing about the high prices of novel medicines, limits on availability...”Published 2022
World Health Organization
|
|
by Perehudoff, Katrina, Mara, Kaitlin, Hoen, Ellen F. M. 't
Published 2021
“... transparency mechanisms in upper-middle- and high-income countries in other regions provide examples of lessons...”Published 2021
HEN, Health Evidence Network, WHO Regional Office for Europe
|
|
by Anderson, Michael, Panteli, Dimitra, Mossialos, Elias
Published 2023
Published 2023
World Health Organization, Regional Office for Europe
|
|
by Sagan, Anna, McDaid, David, Rajan, Selina, Farrington, Jill L.
Published 2020
“... programmes, although they often require expert judgement as well as high quality evidence, including...”Published 2020
World Health Organization, Regional Office for Europe
- 1
- 2